Regarding CCL20, similar to our findings in NPC, its high expression has been confirmed to be associated with poorer prognosis in various cancers, including hepatocellular carcinoma (HCC)34, breast cancer35, colorectal cancer (CRC)36, and pancreatic cancer37. The gene discussed is CCL20; the disease is hepatocellular carcinoma.